Related Experiment Video

Updated: Jul 10, 2026

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

Effect of ecogramostim on HLA class II antigen expression on thyrocytes

C Balázs, A Bokk, E Bodolay

    Lancet (London, England)
    |November 23, 1991
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
    12:09

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

    Published on: February 28, 2019

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
    10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
    07:18

    HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

    Published on: April 11, 2011

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
    12:09

    Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

    Published on: February 28, 2019

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
    10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    Related Concept Videos

    Antigens Involved in Adaptive Immunity01:26

    Antigens Involved in Adaptive Immunity

    An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
    Complete Antigens
    Complete antigens possess both immunogenicity and reactivity.
    T Cell Activation and Clonal Selection01:22

    T Cell Activation and Clonal Selection

    T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
    Naive T cells that have not yet encountered an antigen express two primary CD...

    Articles linked to this work by shared authors, journal, and citation graph.

    Higgs physics at the CLIC electron-positron linear collider.

    The European physical journal. C, Particles and fields·2017

    The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.

    Lupus·2014

    Derailed B cell homeostasis in patients with mixed connective tissue disease.

    Human immunology·2013

    Distinct phenotypes in mixed connective tissue disease: subgroups and survival.

    Lupus·2012

    Gene usage and regulation of Gsα gene expression in thyroid cells.

    Endocrine·2010

    Thyrotropin internalization is directed by a highly conserved motif in the seventh transmembrane region of its receptor.

    Endocrine·2010

    Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

    Lancet (London, England)·2026

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

    Lancet (London, England)·2026

    [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

    Lancet (London, England)·2026

    Regulatory T cells: From Foxp3 to tolerance-inducing therapies.

    The Journal of investigative dermatology·2026

    Prospective Evaluation of Ustekinumab Dose Intensification in Inflammatory Bowel Diseases.

    Gastro hep advances·2026

    Does imepitoin reduce signs of fear and anxiety in dogs frightened by loud noises?

    Veterinary evidence·2026

    Immunophenotyping, activation, and expansion of gamma delta T cells: flow cytometry profiling and ex vivo manipulation strategies.

    Frontiers in immunology·2026

    Correlation between the CD8+ T cell/IFN-γ axis and clinical disease progression at different phases of ITP.

    Frontiers in pediatrics·2026

    Clinical analysis of laparoscopic transabdominal preperitoneal hernioplasty (TAPP) for incarcerated inguinal hernia.

    Medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us